Lens epithelial cell apoptosis initiates diabetic cataractogenesis in the Zucker diabetic fatty rat

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 248, Issue 6, 2010, Pages 811-818

  Kim, Junghyun ^a   Kim, Chan Sik ^a   Sohn, Eunjin ^a   Kim, Hyojun ^a   Jeong, Il Ha ^a   Kim, Jin Sook ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Apoptosis; Diabetic cataract; Inducible nitric oxide; Lens epithelial cell; Nuclear factor kappaB

Indexed keywords

ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BIOACCUMULATION; CATARACT; CATARACTOGENESIS; CELL DAMAGE; CELL NUCLEUS; CONTROLLED STUDY; CYTOPLASM; DIABETES MELLITUS; ENZYME ACTIVATION; ENZYME INDUCTION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GLYCATION; IMMUNOHISTOCHEMISTRY; LENS EPITHELIUM; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; UPREGULATION; ZUCKER DIABETIC FATTY RAT;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CATARACT; DIABETES COMPLICATIONS; EPITHELIAL CELLS; GLYCOSYLATION END PRODUCTS, ADVANCED; HISTOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; IN SITU NICK-END LABELING; LENS, CRYSTALLINE; MALE; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, ZUCKER; RNA, MESSENGER; UP-REGULATION;

EID: 77952089473     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1313-1     Document Type: Article

References (63)

1. Z Kyselova M Stefek V Bauer 2004 Pharmacological prevention of diabetic cataract J Diabetes Complications 18 129 140 10.1016/S1056-8727(03)00009-6 1:STN:280:DC%2BD2c3itlShtg%3D%3D 15120709 (Pubitemid 38559078)
2. KV Ramana B Friedrich A Bhatnagar SK Srivastava 2003 Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells FASEB J 17 315 317 10.1096/fj.02-0722com 1:CAS:528: DC%2BD3sXhtVOjtLk%3D 12490536 (Pubitemid 36292957)
3. KR Hightower JR Reddan JP McCready DC Dziedzic 1994 Lens epithelium: a primary target of UVB irradiation Exp Eye Res 59 557 564 10.1006/exer.1994.1141 1:CAS:528:DyaK2MXisVGkurY%3D 9492757 (Pubitemid 24359875)
4. WC Li JR Kuszak K Dunn RR Wang W Ma GM Wang A Spector M Leib AM Cotliar M Weiss, et al. 1995 Lens epithelial cell apoptosis appears to be a common cellular basis for non-congenital cataract development in humans and animals J Cell Biol 130 169 181 10.1083/jcb.130.1.169 1:CAS:528:DyaK2MXmsFWhu7s%3D 7790371
5. WC Li A Spector 1996 Lens epithelial cell apoptosis is an early event in the development of UVB-induced cataract Free Radic Biol Med 20 301 311 10.1016/0891-5849(96)02050-3 1:CAS:528:DyaK28XhvVWitr0%3D 8720900 (Pubitemid 26077852)
6. Y Takamura E Kubo S Tsuzuki Y Akagi 2003 Apoptotic cell death in the lens epithelium of rat sugar cataract Exp Eye Res 77 51 57 10.1016/S0014-4835(03) 00083-6 1:CAS:528:DC%2BD3sXkvVCgtbk%3D 12823987 (Pubitemid 36776273)
7. LJ Hofseth AI Robles MG Espey CC Harris 2005 Nitric oxide is a signaling molecule that regulates gene expression Methods Enzymol 396 326 340 10.1016/S0076-6879(05)96027-8 1:CAS:528:DC%2BD28Xot1yhsb0%3D 16291242 (Pubitemid 41603556)
8. D Sumi LJ Ignarro 2004 Regulation of inducible nitric oxide synthase expression in advanced glycation end product-stimulated raw 264.7 cells: the role of heme oxygenase-1 and endogenous nitric oxide Diabetes 53 1841 1850 10.2337/diabetes.53.7.1841 1:CAS:528:DC%2BD2cXlslWgtLc%3D 15220209 (Pubitemid 38857043)
9. H Zhang X Chen X Teng C Snead JD Catravas 1998 Molecular cloning and analysis of the rat inducible nitric oxide synthase gene promoter in aortic smooth muscle cells Biochem Pharmacol 55 1873 1880 10.1016/S0006-2952(98)00078-1 1:CAS:528:DyaK1cXjvVehtrY%3D 9714306 (Pubitemid 28305270)
10. CJ Lowenstein EW Alley P Raval AM Snowman SH Snyder SW Russell WJ Murphy 1993 Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide Proc Natl Acad Sci U S A 90 9730 9734 10.1073/pnas.90.20.9730 1:CAS:528:DyaK2cXitVyk 7692452 (Pubitemid 23315860)
11. QW Xie Y Kashiwabara C Nathan 1994 Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase J Biol Chem 269 4705 4708 1:CAS:528:DyaK2cXitV2qu74%3D 7508926 (Pubitemid 24239438)
12. KF Beck RB Sterzel 1996 Cloning and sequencing of the proximal promoter of the rat iNOS gene: activation of NFkappaB is not sufficient for transcription of the iNOS gene in rat mesangial cells FEBS Lett 394 263 267 10.1016/0014-5793(96)00966-0 1:CAS:528:DyaK28XmtV2isbs%3D 8830655 (Pubitemid 26341455)
13. ME de Vera RA Shapiro AK Nussler JS Mudgett RL Simmons SM Morris Jr TR Billiar DA Geller 1996 Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter Proc Natl Acad Sci U S A 93 1054 1059 10.1073/pnas.93.3.1054 8577713 (Pubitemid 26052841)
14. HY Yun VL Dawson TM Dawson 1997 Nitric oxide in health and disease of the nervous system Mol Psychiatry 2 300 310 10.1038/sj.mp.4000272 1:STN:280:DyaK2szovFCrug%3D%3D 9246670
15. C Nathan QW Xie 1994 Nitric oxide synthases: roles, tolls, and controls Cell 78 915 918 10.1016/0092-8674(94)90266-6 1:CAS:528:DyaK2cXmsV2jsLg%3D 7522969 (Pubitemid 24292319)
16. B Brune A von Knethen KB Sandau 1998 Nitric oxide and its role in apoptosis Eur J Pharmacol 351 261 272 10.1016/S0014-2999(98)00274-X 1:CAS:528:DyaK1cXltFSitLs%3D 9721017 (Pubitemid 28321461)
17. F Becquet Y Courtois O Goureau 1997 Nitric oxide in the eye: multifaceted roles and diverse outcomes Surv Ophthalmol 42 71 82 10.1016/S0039-6257(97) 84043-X 1:STN:280:DyaK2svhtVeqtw%3D%3D 9265703 (Pubitemid 27333186)
18. GC Chiou 2001 Review: effects of nitric oxide on eye diseases and their treatment J Ocul Pharmacol Ther 17 189 198 10.1089/10807680151125555 1:CAS:528:DC%2BD3MXivFOqs78%3D 11324986
19. M Inomata M Hayashi S Shumiya S Kawashima Y Ito 2001 Involvement of inducible nitric oxide synthase in cataract formation in Shumiya cataract rat (SCR) Curr Eye Res 23 307 311 10.1076/ceyr.23.4.307.5455 1:STN:280: DC%2BD387ovVGmtg%3D%3D 11852433 (Pubitemid 34161304)
20. Y Ito T Nabekura M Takeda M Nakao M Terao R Hori M Tomohiro 2001 Nitric oxide participates in cataract development in selenite-treated rats Curr Eye Res 22 215 220 10.1076/ceyr.22.3.215.5516 1:STN:280:DC%2BD3MvhtFOmsA%3D%3D 11462158 (Pubitemid 32881427)
21. S Ao C Kikuchi T Ono Y Notsu 1991 Effect of instillation of aldose reductase inhibitor FR74366 on diabetic cataract Invest Ophthalmol Vis Sci 32 3078 3083 1:STN:280:DyaK38%2FktVOrsg%3D%3D 1834606
22. EJ Sohn CS Kim YS Kim DH Jung DS Jang YM Lee JS Kim 2007 Effects of magnolol (5, 5′-diallyl-2, 2′-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats Life Sci 80 468 475 10.1016/j.lfs.2006.09.037 1:CAS:528:DC%2BD2sXhtVWqtg%3D%3D 17070554 (Pubitemid 46013908)
23. F Knerlich L Schilling C Gorlach M Wahl H Ehrenreich AL Siren 1999 Temporal profile of expression and cellular localization of inducible nitric oxide synthase, interleukin-1beta and interleukin converting enzyme after cryogenic lesion of the rat parietal cortex Brain Res Mol Brain Res 68 73 87 10.1016/S0169-328X(99)00064-9 1:CAS:528:DyaK1MXjs1eiur8%3D 10320785 (Pubitemid 29243996)
24. J Kim C Choi C Chae 2003 Pathogenesis of postweaning multisystemic wasting syndrome reproduced by co-infection with Korean isolates of porcine circovirus 2 and porcine parvovirus J Comp Pathol 128 52 59 10.1053/jcpa.2002. 0605 1:STN:280:DC%2BD3s%2FisFSntA%3D%3D 12531687 (Pubitemid 36131165)
25. MA Hernandez-Presa C Gomez-Guerrero J Egido 1999 In situ non-radioactive detection of nuclear factors in paraffin sections by Southwestern histochemistry Kidney Int 55 209 214 10.1046/j.1523-1755.1999.00226.x 1:CAS:528: DyaK1MXjtVantQ%3D%3D 9893129 (Pubitemid 29004252)
26. C Charriaut-Marlangue Y Ben-Ari 1995 A cautionary note on the use of the TUNEL stain to determine apoptosis NeuroReport 7 61 64 1:STN:280: DyaK28zlt1Wmuw%3D%3D 8742417
27. S Yamagishi M Takeuchi T Matsui K Nakamura T Imaizumi H Inoue 2005 Angiotensin II augments advanced glycation end product-induced pericyte apoptosis through RAGE overexpression FEBS Lett 579 4265 4270 10.1016/j.febslet.2005.06.058 1:CAS:528:DC%2BD2MXnslygt7c%3D 16051229 (Pubitemid 41116350)
28. WG Robison Jr N Houlder JH Kinoshita 1990 The role of lens epithelium in sugar cataract formation Exp Eye Res 50 641 646 10.1016/0014-4835(90)90107-6 1:CAS:528:DyaK3cXkslGrtLg%3D 2373160 (Pubitemid 20191293)
29. JB Mackic FN Ross-Cisneros JG McComb I Bekhor MH Weiss R Kannan BV Zlokovic 1994 Galactose-induced cataract formation in guinea pigs: morphologic changes and accumulation of galactitol Invest Ophthalmol Vis Sci 35 804 810 1:STN:280:DyaK2c7ntFGisg%3D%3D 8125742
30. N Toda M Nakanishi-Toda 2007 Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy Prog Retin Eye Res 26 205 238 10.1016/j.preteyeres. 2007.01.004 1:CAS:528:DC%2BD2sXjs1OntL8%3D 17337232 (Pubitemid 46498800)
31. O Goureau J Bellot B Thillaye Y Courtois Y de Kozak 1995 Increased nitric oxide production in endotoxin-induced uveitis. Reduction of uveitis by an inhibitor of nitric oxide synthase J Immunol 154 6518 6523 1:CAS:528: DyaK2MXntFyisrc%3D 7539024
32. CL Kao CK Chou DC Tsai WM Hsu JH Liu CS Wang JC Lin CC Wu CH Peng CJ Chang SH Chiou 2002 Nitric oxide levels in the aqueous humor in cataract patients J Cataract Refract Surg 28 507 512 10.1016/S0886-3350(01)01102-6 11973099 (Pubitemid 34208028)
33. DC Tsai SH Chiou FL Lee CK Chou SJ Chen CH Peng YH Kuo CF Chen LL Ho WM Hsu 2003 Possible involvement of nitric oxide in the progression of diabetic retinopathy Ophthalmologica 217 342 346 10.1159/000071349 1:CAS:528: DC%2BD3sXmsVarsLY%3D 12913324 (Pubitemid 36993956)
34. N Nagai Y Liu T Fukuhata Y Ito 2006 Inhibitors of inducible nitric oxide synthase prevent damage to human lens epithelial cells induced by interferon-gamma and lipopolysaccharide Biol Pharm Bull 29 2077 2081 10.1248/bpb.29.2077 1:CAS:528:DC%2BD28XhtlSjurvN 17015954 (Pubitemid 44510812)
35. EM Olofsson SL Marklund A Behndig 2007 Glucose-induced cataract in CuZn-SOD null lenses: an effect of nitric oxide? Free Radic Biol Med 42 1098 1105 10.1016/j.freeradbiomed.2007.01.012 1:CAS:528:DC%2BD2sXivVantLk%3D 17349936 (Pubitemid 46356903)
36. CG Chamberlain KJ Mansfield A Cerra 2008 Nitric oxide, a survival factor for lens epithelial cells Mol Vis 14 983 991 1:CAS:528:DC%2BD1cXntleku7k%3D 18523663
37. CQ Li GN Wogan 2005 Nitric oxide as a modulator of apoptosis Cancer Lett 226 1 15 10.1016/j.canlet.2004.10.021 1:CAS:528:DC%2BD2MXlvFeitLg%3D 16004928 (Pubitemid 40943425)
38. HT Chung HO Pae BM Choi TR Billiar YM Kim 2001 Nitric oxide as a bioregulator of apoptosis Biochem Biophys Res Commun 282 1075 1079 10.1006/bbrc.2001.4670 1:CAS:528:DC%2BD3MXis1eru70%3D 11302723 (Pubitemid 32912833)
39. KD Kroncke K Fehsel C Suschek V Kolb-Bachofen 2001 Inducible nitric oxide synthase-derived nitric oxide in gene regulation, cell death and cell survival Int Immunopharmacol 1 1407 1420 10.1016/S1567-5769(01)00087-X 1:CAS:528:DC%2BD3MXlvFSmtrk%3D 11515808 (Pubitemid 32622787)
40. GN Antonova CM Snead AS Antonov C Dimitropoulou RC Venema JD Catravas 2007 Nitric oxide preconditioning regulates endothelial monolayer integrity via the heat shock protein 90-soluble guanylate cyclase pathway Am J Physiol Heart Circ Physiol 292 H893 H903 10.1152/ajpheart.00498.2006 1:CAS:528: DC%2BD2sXjt1Gnsbs%3D 17012359
41. HJ Kwak KM Park S Lee HJ Lim SH Go SM Eom HY Park 2006 Preconditioning with low concentration NO attenuates subsequent NO-induced apoptosis in vascular smooth muscle cells via HO-1-dependent mitochondrial death pathway Toxicol Appl Pharmacol 217 176 184 10.1016/j.taap.2006.08.010 1:CAS:528:DC%2BD28Xht1SmsLbL 17027882 (Pubitemid 44711968)
42. YT Tai YG Cherng CC Chang YP Hwang JT Chen RM Chen 2007 Pretreatment with low nitric oxide protects osteoblasts from high nitric oxide-induced apoptotic insults through regulation of c-Jun N-terminal kinase/c-Jun-mediated Bcl-2 gene expression and protein translocation J Orthop Res 25 625 635 10.1002/jor.20365 1:CAS:528:DC%2BD2sXlt1Ghtbs%3D 17262823 (Pubitemid 46730515)
43. Y Yoshioka T Kitao T Kishino A Yamamuro S Maeda 2006 Nitric oxide protects macrophages from hydrogen peroxide-induced apoptosis by inducing the formation of catalase J Immunol 176 4675 4681 1:CAS:528:DC%2BD28XjtV2gs7Y%3D 16585560
44. C Brynczka BA Merrick 2007 Nerve growth factor potentiates p53 DNA binding but inhibits nitric oxide-induced apoptosis in neuronal PC12 cells Neurochem Res 32 1573 1585 10.1007/s11064-007-9362-5 1:CAS:528: DC%2BD2sXotVWksrs%3D 17592775 (Pubitemid 47094420)
45. SL Pan JH Guh YL Chang SC Kuo FY Lee CM Teng 2004 YC-1 prevents sodium nitroprusside-mediated apoptosis in vascular smooth muscle cells Cardiovasc Res 61 152 158 10.1016/j.cardiores.2003.09.013 1:CAS:528:DC%2BD2cXjtFCisw%3D%3D 14732212 (Pubitemid 38056691)
46. JD MacMicking C Nathan G Hom N Chartrain DS Fletcher M Trumbauer K Stevens QW Xie K Sokol N Hutchinson, et al. 1995 Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase Cell 81 641 650 10.1016/0092-8674(95)90085-3 1:CAS:528:DyaK2MXlvVGgu7w%3D 7538909
47. Z Zhang K Yao C Jin 2009 Apoptosis of lens epithelial cells induced by high concentration of glucose is associated with a decrease in caveolin-1 levels Mol Vis 15 2008 2017 1:CAS:528:DC%2BD1MXht1Ghs7bE 19816600
48. ZM Wu XX Yin L Ji YY Gao YM Pan Q Lu JY Wang 2008 Ginkgo biloba extract prevents against apoptosis induced by high glucose in human lens epithelial cells Acta Pharmacol Sin 29 1042 1050 10.1111/j.1745-7254.2008.00837.x 1:CAS:528:DC%2BD1cXhtV2rurnK 18718173
49. S Franke J Dawczynski J Strobel T Niwa P Stahl G Stein 2003 Increased levels of advanced glycation end products in human cataractous lenses J Cataract Refract Surg 29 998 1004 10.1016/S0886-3350(02)01841-2 12781289 (Pubitemid 36622675)
50. ID Bras CM Colitz DF Kusewitt H Chandler P Lu AJ Gemensky-Metzler DA Wilkie 2007 Evaluation of advanced glycation end-products in diabetic and inherited canine cataracts Graefes Arch Clin Exp Ophthalmol 245 249 257 10.1007/s00417-006-0293-7 1:CAS:528:DC%2BD2sXhvVejurY%3D 16896921 (Pubitemid 46291455)
51. YS Kim NH Kim SW Lee YM Lee DS Jang JS Kim 2007 Effect of protocatechualdehyde on receptor for advanced glycation end products and TGF-beta1 expression in human lens epithelial cells cultured under diabetic conditions and on lens opacity in streptozotocin-diabetic rats Eur J Pharmacol 569 171 179 10.1016/j.ejphar.2007.05.054 1:CAS:528:DC%2BD2sXovFOjsrc%3D 17597607 (Pubitemid 47198248)
52. SD Yan AM Schmidt GM Anderson J Zhang J Brett YS Zou D Pinsky D Stern 1994 Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins J Biol Chem 269 9889 9897 1:CAS:528:DyaK2cXis1Ogsrg%3D 8144582
53. G Romeo WH Liu V Asnaghi TS Kern M Lorenzi 2002 Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes Diabetes 51 2241 2248 10.2337/diabetes.51.7.2241 1:CAS:528:DC%2BD38Xlt1Wks78%3D 12086956
54. R Singh A Barden T Mori L Beilin 2001 Advanced glycation end-products: a review Diabetologia 44 129 146 10.1007/s001250051591 1:CAS:528: DC%2BD3MXntlSltg%3D%3D 11270668 (Pubitemid 32156196)
55. H Vlassara R Bucala L Striker 1994 Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging Lab Invest 70 138 151 1:CAS:528:DyaK2cXksFCksLg%3D 8139257
56. M Alves VC Calegari DA Cunha MJ Saad LA Velloso EM Rocha 2005 Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats Diabetologia 48 2675 2681 10.1007/s00125-005-0010-9 1:CAS:528:DC%2BD2MXht1Omu7%2FI 16283249 (Pubitemid 41738237)
57. SB Hong KW Lee JT Handa CK Joo 2000 Effect of advanced glycation end products on lens epithelial cells in vitro Biochem Biophys Res Commun 275 53 59 10.1006/bbrc.2000.3245 1:CAS:528:DC%2BD3cXls1Cntr8%3D 10944440 (Pubitemid 30663628)
58. M Brownlee 1995 Advanced protein glycosylation in diabetes and aging Annu Rev Med 46 223 234 10.1146/annurev.med.46.1.223 1:CAS:528:DyaK2MXkvFSks7g%3D 7598459
59. M Yokoi SI Yamagishi M Takeuchi K Ohgami T Okamoto W Saito M Muramatsu T Imaizumi S Ohno 2005 Elevations of AGE and vascular endothelial growth factor with decreased total antioxidant status in the vitreous fluid of diabetic patients with retinopathy Br J Ophthalmol 89 673 675 10.1136/bjo.2004.055053 1:STN:280:DC%2BD2M3nvVGguw%3D%3D 15923499 (Pubitemid 40780571)
60. S Zarina HR Zhao EC Abraham 2000 Advanced glycation end products in human senile and diabetic cataractous lenses Mol Cell Biochem 210 29 34 10.1023/A:1007015416572 1:CAS:528:DC%2BD3cXmtVWgsbc%3D 10976755
61. TA Kalfa ME Gerritsen EC Carlson AJ Binstock EC Tsilibary 1995 Altered proliferation of retinal microvascular cells on glycated matrix Invest Ophthalmol Vis Sci 36 2358 2367 1:STN:280:DyaK28%2Fks1KksQ%3D%3D 7591625
62. TC Moore JE Moore Y Kaji N Frizzell T Usui V Poulaki IL Campbell AW Stitt TA Gardiner DB Archer AP Adamis 2003 The role of advanced glycation end products in retinal microvascular leukostasis Invest Ophthalmol Vis Sci 44 4457 4464 10.1167/iovs.02-1063 14507893 (Pubitemid 37186283)
63. AW Stitt JE Moore JA Sharkey G Murphy DA Simpson R Bucala H Vlassara DB Archer 1998 Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy Invest Ophthalmol Vis Sci 39 2517 2523 1:STN:280:DyaK1M%2Fnt1Grsg%3D%3D 9856760